Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases

Conditions

• Leptomeningeal Metastasis
• NSCLC
• Intrathecal Chemotherapy
• Tyrosine Kinase Inhibitor

Interventions

• DRUG: Firmonertinib
• DRUG: Intrathecal injection of pemetrexed

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology